Cellular Interactions with Thrombospondin

细胞与血小板反应蛋白的相互作用

基本信息

项目摘要

CD47 is a marker of self and a signaling receptor for thrombospondin-1 that is also an enriched membrane component of extracellular vesicles (EVs) released by various cell types. Previous studies identified CD47-dependent functional effects of T cell EVs on target cells, mediated by delivery of their RNA contents, and enrichment of specific subsets of coding and noncoding RNAs in CD47+ EVs. Here, transcriptomic analyses of EVs released by human and murine T cells revealed a global CD47-dependent enrichment of 5'-7-methylguanosine-capped microRNAs and mRNAs in EVs relative to levels in the cells. Knockdown or loss of CD47 in wild type Jurkat T cells or treatment with thrombospondin-1 enhanced levels of specific capped-RNAs released in EVs, and re-expressing CD47 in null cells decreased their levels. Mass spectrometry and co-immunoprecipitation identified specific interactions of CD47 with components of the exportin-1/Ran nuclear export complex and its known cargo proteins and between the CD47 cytoplasmic adapter ubiquilin-1 and the exportin-1/Ran complex. Interaction with CD47 was inhibited following alkylation of exportin-1 at Cys528 by leptomycin B. Leptomycin B modification of exportin-1 increased levels of cap-dependent RNAs and their association with exportin-1 in EVs released from wild type but not CD47-deficient cells. Therefore, CD47 regulates the trafficking of cap-dependent RNAs to EVs through physical interactions with the exportin-1/Ran transport complex. Targeted gene disruption in mice has provided valuable insights into the functions of matricellular proteins. Apart from missense and loss of function mutations that have been associated with inherited diseases, however, their functions in humans remain unclear. The availability of deep exome sequencing data from over 140,000 individuals in the Genome Aggregation Database provided an opportunity to examine intolerance to loss of function and missense mutations in human matricellular genes. The probability of loss-of-function intolerance (pLI) differed widely within members of the thrombospondin, CYR61/CTGF/NOV (CCN), tenascin, small integrin-binding ligand N-linked glycoproteins (SIBLING), and secreted protein, acidic and rich in cysteine (SPARC) gene families. Notably, pLI values in humans had limited correlation with viability of the corresponding homozygous null mice. Among the thrombospondins, only THBS1 was highly loss-intolerant (pLI = 1). In contrast, Thbs1 is not essential for viability in mice. Several known thrombospondin-1 receptors were similarly loss-intolerant, although thrombospondin-1 is not the exclusive ligand for some of these receptors. The frequencies of missense mutations in THBS1 and the gene encoding its signaling receptor CD47 indicated conservation of some residues implicated in specific receptor binding. Deficits in missense mutations were also observed for other thrombospondin genes and for SPARC, SPOCK1, SPOCK2, TNR, and DSPP. The intolerance of THBS1 to loss of function in humans and elevated pLI values for THBS2, SPARC, SPOCK1, TNR, and CCN1 support important functions for these matricellular protein genes in humans, some of which may relate to functions in reproduction or responding to environmental stresses.
CD47是自我的标记和血小板传播1的信号受体,它也是各种细胞类型释放的细胞外囊泡(EV)的富集膜成分。先前的研究确定了T细胞EVS对靶细胞的CD47依赖性功能效应,通过递送其RNA含量介导,以及在CD47+ EV中富集编码和非编码RNA的特定子集。在这里,人和鼠T细胞释放的电动汽车的转录组分析显示,与细胞水平相对于电动汽车中的5'-7-7-甲基鸟苷笼型microRNA和mRNA的全球CD47依赖性富集。野生型Jurkat T细胞中CD47的敲低或丢失或用血小板蛋白1的处理增强了EV中释放的特定限制RNA水平,并在零细胞中重新表达CD47降低了其水平。质谱和共免疫沉淀确定了CD47与Exportin-1/RAN核出口复合物及其已知的货物蛋白的特定相互作用,以及CD47细胞质适配器Ubiquilin-1和Exportin-1/RAN复合物之间的特定相互作用。嗜血霉素B的烷基化在Cys528上的Exportin-1烷基化烷基化B.嗜经霉素B的EXTORTIN-1的相互作用在Cys528上的相互作用增加了cap依赖性RNA的水平及其与野生型释放的EVS中的Evelin-1的相关性,但不是CD47缺乏的细胞。因此,CD47通过与Exportin-1/RAN运输复合物的物理相互作用来调节CAP依赖性RNA对EV的运输。小鼠的靶向基因破坏为矩阵蛋白的功能提供了宝贵的见解。但是,除了与遗传疾病相关的功能突变的丧失外,它们在人类中的功能仍然不清楚。来自基因组聚集数据库中140,000多名个体的深层外显子组测序数据提供了一个机会,可以检查人类母细胞基因中功能丧失和功能丧失和错义突变的不耐受。功能丧失不宽容(PLI)的可能性在血小板蛋白,CYR61/CTGF/NOV(CCN),Tenascin,小内整合素结合配体N-链接糖蛋白(sibling)(sibling),酸性蛋白质,酸性蛋白质,酸性蛋白质,酸性蛋白质(Sparcarce)(Sparc)的Gene formals(Sparc)Gene中的可能性差异很大。值得注意的是,人类中的PLI值与相应纯合子无效小鼠的生存力的相关性有限。在血小板传播中,只有THBS1是高度损失智力(PLI = 1)。相比之下,THBS1对于小鼠的生存能力并不是必需的。尽管某些受体中的几种已知的血小板传播1受体同样具有损失智能剂,但并不是其中一些受体的独家配体。 THBS1中错义突变的频率和编码其信号受体CD47的基因表明保存了与特定受体结合有关的某些残基。对于其他血小板传播基因以及SPARC,SPOCK1,SPOCK2,TNR和DSPP,还观察到错义突变的缺陷。 THBS1对人类功能丧失的不耐受和THBS2,SPARC,SPOCK1,TNR和CCN1的PLI值的升高支持人类这些基质蛋白基因的重要功能,其中一些可能与生殖或对环境应力的反应有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(5)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

david d roberts其他文献

david d roberts的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('david d roberts', 18)}}的其他基金

Roles of Glycoconjugates and Redox Signaling in Tumor Biology
糖缀合物和氧化还原信号在肿瘤生物学中的作用
  • 批准号:
    8350063
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Host Colonization and Vascular Dissemination of Candida albicans
白色念珠菌的宿主定植和血管传播
  • 批准号:
    9556773
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Regulation of Metastasis and Angiogenesis by Autotaxin
自分泌运动因子对转移和血管生成的调节
  • 批准号:
    7291956
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Cellular Interactions with Thrombospondin
细胞与血小板反应蛋白的相互作用
  • 批准号:
    10262702
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Regulation of Metastasis and Angiogenesis by Autotaxin
自分泌运动因子对转移和血管生成的调节
  • 批准号:
    7338795
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Cellular Interactions with Thrombospondin
细胞与血小板反应蛋白的相互作用
  • 批准号:
    8554028
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Cellular Interactions with Thrombospondin
细胞与血小板反应蛋白的相互作用
  • 批准号:
    10702998
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Roles of Glycoconjugates and Redox Signaling in Tumor Biology
糖缀合物和氧化还原信号在肿瘤生物学中的作用
  • 批准号:
    9780179
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Cellular Interactions with Thrombospondin
细胞与血小板反应蛋白的相互作用
  • 批准号:
    8763691
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:
Cellular Interactions with Thrombospondin
细胞与血小板反应蛋白的相互作用
  • 批准号:
    10926575
  • 财政年份:
  • 资助金额:
    $ 156.25万
  • 项目类别:

相似国自然基金

用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
  • 批准号:
    32301097
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
  • 批准号:
    82300739
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
  • 批准号:
    32371426
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
  • 批准号:
    82360379
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
  • 批准号:
    82302221
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
  • 批准号:
    10438061
  • 财政年份:
    2022
  • 资助金额:
    $ 156.25万
  • 项目类别:
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
  • 批准号:
    10580070
  • 财政年份:
    2022
  • 资助金额:
    $ 156.25万
  • 项目类别:
Oral Epigallocatechin Gallate (EGCG) for Treatment of Cisplatin Ototoxicity
口服表没食子儿茶素没食子酸酯(EGCG)治疗顺铂耳毒性
  • 批准号:
    10163157
  • 财政年份:
    2018
  • 资助金额:
    $ 156.25万
  • 项目类别:
Project 1: Novel Pharmacological Inhibitors of Chemical Vesicants-mediated Cutaneous Injury
项目1:化学糜烂介导的皮肤损伤的新型药理抑制剂
  • 批准号:
    10249113
  • 财政年份:
    2018
  • 资助金额:
    $ 156.25万
  • 项目类别:
Optimization of AEOL10150 treatment of sulfur mustard-induced lung toxidrome in a pig model
AEOL10150 治疗猪芥子气肺中毒模型的优化
  • 批准号:
    10626938
  • 财政年份:
    2018
  • 资助金额:
    $ 156.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了